Geron (GERN) Says First Patient Treated in Embryonic Stem Cell Study
Tweet Send to a Friend
Shares of Geron Corporation (Nasdaq: GERN) are higher this morning after announcing enrollment ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


